TMAO pathway impacts infarct size and functional impairment in preclinical stroke models
Hazen group to pursue research programs in atherosclerosis, thrombosis, obesity
Two new studies add insights and home in on therapeutic targets
Study heralds potential new approach to cardiometabolic diseases
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy